Healthcare of Ontario Pension Plan Trust Fund Acquires Shares of 552,367 Marsh & McLennan Companies, Inc. $MRSH

Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 552,367 shares of the financial services provider’s stock, valued at approximately $102,475,000.

A number of other hedge funds have also recently bought and sold shares of MRSH. Solstein Capital LLC acquired a new stake in Marsh & McLennan Companies during the 4th quarter valued at approximately $25,000. KERR FINANCIAL PLANNING Corp acquired a new stake in Marsh & McLennan Companies during the 4th quarter valued at approximately $27,000. Golden State Wealth Management LLC acquired a new stake in Marsh & McLennan Companies during the 4th quarter valued at approximately $27,000. Atlas Capital Advisors Inc. acquired a new stake in Marsh & McLennan Companies during the 4th quarter valued at approximately $28,000. Finally, City Holding Co. acquired a new stake in Marsh & McLennan Companies during the 4th quarter valued at approximately $29,000. Institutional investors and hedge funds own 87.99% of the company’s stock.

Marsh & McLennan Companies Stock Up 0.3%

Shares of Marsh & McLennan Companies stock opened at $168.67 on Friday. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. The firm has a market cap of $81.49 billion, a price-to-earnings ratio of 21.08, a price-to-earnings-growth ratio of 2.46 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a 1-year low of $156.60 and a 1-year high of $220.32.

Marsh & McLennan Companies (NYSE:MRSH) last announced its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating the consensus estimate of $3.21 by $0.08. The firm had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The firm’s quarterly revenue was up 7.6% on a year-over-year basis. On average, analysts predict that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on MRSH. Raymond James Financial upgraded Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 price objective for the company in a research note on Tuesday, February 17th. JPMorgan Chase & Co. reduced their target price on Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating on the stock in a report on Thursday, April 9th. Weiss Ratings downgraded Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Barclays reduced their target price on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a report on Wednesday, April 8th. Finally, Morgan Stanley reduced their target price on Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating on the stock in a report on Monday, April 6th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $200.19.

Insiders Place Their Bets

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the sale, the chief executive officer owned 116,811 shares of the company’s stock, valued at $18,889,506.81. The trade was a 12.48% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is owned by insiders.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.